Advertisement
News
Subscribe to MDT Magazine News

AstraZeneca, Biogen look externally for new drug candidates

May 23, 2011 10:37 am | by Mass High Tech: The Journal of New England Technology | Comments

AstraZeneca Plc and Biogen Idec Inc. have joined the ranks of local large biotech and pharmaceutical companies like Pfizer Inc., which, facing looming patent expirations and unproductive pipelines, are reaching outside their own walls to find new drug candidates.

Pentrexyl Forte Natural: Recall - Misleading Packaging

May 23, 2011 10:30 am | by U.S. Food & Drug Administration | Comments

Dietary supplement product packaging may cause it to be confused with an antibiotic product.

FDA Schedules Advisory Committee Meeting to Discuss BLA for VEGF Trap-Eye for the Treatment of Wet Age-Related Macular Degeneration

May 23, 2011 9:35 am | by Bio-Medicine.Org | Comments

TARRYTOWN, N.Y. May 23, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) today announced that the U.S. Food and Drug Administration (FDA) has informed the company that it has scheduled a Dermatologic and Ophthalmic Drugs Advisory Committee Meeting to be held on June 17, 2011 to...

TOPICS:
Advertisement

Heska to Present at SunTrust Robinson Humphrey's Annual Veterinary and Dental Conference

May 23, 2011 9:33 am | by Bio-Medicine.Org | Comments

LOVELAND, Colo., May 23, 2011 /- Heska Corporation (NASDAQ: HSKA ) today announced it will present at the SunTrust Robinson Humphrey Annual Veterinary and Dental Conference on Wednesday, June 1, 2011.  The presentation will be at the Le Parker Meridien Hotel at 119 West 56th Street...

TOPICS:

Class I Medical Device Recall: Beckman Coulter, Inc., Synchron LX Clinical Systems Ion Selective Electrolyte (ISE) Flow Cell

May 23, 2011 9:30 am | by U.S. Food & Drug Administration | Comments

Reason for Recall: There may be ratio pump wear, silver iodide build-up on the chloride electrode, microbial contamination, general non-ISE hardware, and maintenance in the instruments (ion selective electrolyte flow cell) which may cause incorrect...

Use of TIGR® Matrix Surgical Mesh in Multi-Center Randomized Controlled TRAM Flap Study Passes 20 Patient Mark and Wins Praise from Participating Surgeons

May 23, 2011 8:36 am | by Bio-Medicine.Org | Comments

SINGAPORE, May 23, 2011 /- Singapore company Novus Scientific Pte. Ltd announced that the TRAM Flap study (Abdominal Wall Closure After Lipectomy, TRAM/DIEP Flap - Comparison of TIGR® (100% Resorbable) vs Polypropylene (Permanent) Mesh) has passed the 20 patient mark, representing...

AACR Calls for Letters of Intent for a Stand Up To Cancer-Melanoma Research Alliance Dream Team

May 23, 2011 8:33 am | by AACR | Comments

Tweet PHILADELPHIA - Stand Up To Cancer (SU2C) and the Melanoma Research Alliance (MRA), along with the American Association for Cancer Research, call upon the cancer research community to submit Letters of Intent for a new Dream Team dedicated to melanoma research. The SU2C-MRA Melanoma...

TOPICS:

Florida Hospital First U.S. Site to Adopt New Automated Laboratory Solution From Roche

May 23, 2011 8:33 am | by Bio-Medicine.Org | Comments

ORLANDO, Fla., May 23, 2011 /- Florida Hospital is improving its laboratory testing capabilities with new state-of-the-art equipment from Roche Diagnostics that is designed to help labs increase their testing capacity and deliver reliable results with greater efficiency. The high-volume,...

TOPICS:
Advertisement

Earnings Preview: Medtronic to report 4Q Tuesday

May 23, 2011 7:45 am | by The Associated Press | Comments

Medtronic Inc., the world's largest medical device maker, announces its fiscal fourth-quarter and full-year earnings Tuesday morning before markets open.WHAT TO WATCH FOR: Two weeks ago Medtronic announced it had selected the head of General Electric's Healthcare unit to serve as its new chief...

Vertex hepatitis C drug gets FDA OK

May 23, 2011 7:35 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. has won approval from the U.S. Food and Drug Administration for its hepatitis C drug, Incivek. The Cambridge biotechnology firm was confident earlier this month that it would get the nod after an FDA advisory panel recommended approval of the treatment.

Siemens Honored by Department of Defense Agency for Supporting Massachusetts Guardsman

May 23, 2011 7:32 am | by Bio-Medicine.Org | Comments

NORWOOD, Mass., May, 23, 2011 /- The Norwood, Massachusetts facility of Siemens Healthcare Diagnostics (NYSE: SI ) was honored today with a 'Patriot Award' and an 'Above and Beyond Award' from the Employer Support of the Guard and Reserve (ESGR), a Department of Defense agency. Both...

TOPICS:

Sickle cell-focused biotech AesRx lands $1.38M

May 23, 2011 6:35 am | by Mass High Tech: The Journal of New England Technology | Comments

AesRx LLC, a biotech firm in Newton, has secured about $1.38 million in a debt and securities financing, according to a regulatory filing. The company makes a treatment for sickle cell disease and a drug target for lower intestine inflammatory diseases.

Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement

May 23, 2011 6:34 am | by Bio-Medicine.Org | Comments

INDIANAPOLIS, May 23, 2011 /- Eli Lilly and Company (NYSE: LLY ) today announced that it has signed agreements with private investors Care Capital and NovaQuest Capital to establish BioCritica Inc., a newly-formed and privately-held biotechnology company. BioCritica, based in Central...

TOPICS:

Texas Instruments introduces first quad-channel 16-bit, 100 MSPS ADC for faster, smaller medical imaging equipment

May 23, 2011 6:34 am | by Bio-Medicine.Org | Comments

DALLAS, May 23, 2011 /- Texas Instruments Incorporated (TI) (NYSE: TXN ) today introduced the first quad-channel, 16-bit analog-to-digital converter (ADC) for medical imaging applications, such as magnetic resonance imaging (MRI). The ADS5263 meets designers' needs for clear, crisp...

TOPICS:

CardioGenics to Present at the 7th Annual Spring Growth Stock Conference Hosted by Security Research Associates, Inc.

May 23, 2011 6:32 am | by Bio-Medicine.Org | Comments

MISSISSAUGA, Ontario, May 23, 2011 /- CardioGenics Holdings Inc. (CGNH: OTCB) announced today that Dr. Yahia Gawad, CEO of CardioGenics will be presenting at the 7th Annual Spring Growth Stock Conference hosted by Security Research Associates, Inc.  The conference will be held on...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading